Marrone Bio Innovations, Inc. (MBII): Price and Financial Metrics


Marrone Bio Innovations, Inc. (MBII): $0.80

-0.20 (-20.19%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MBII to Watchlist
Sign Up

Industry: Chemicals


Ranked

of

in industry

MBII POWR Grades

  • MBII scores best on the Momentum dimension, with a Momentum rank ahead of 64.41% of US stocks.
  • The strongest trend for MBII is in Growth, which has been heading down over the past 99 days.
  • MBII's current lowest rank is in the Sentiment metric (where it is better than 6.19% of US stocks).

MBII Stock Summary

  • MBII has a higher market value than 26.01% of US stocks; more precisely, its current market capitalization is $180,149,383.
  • The capital turnover (annual revenue relative to shareholder's equity) for MBII is 1.94 -- better than 73.68% of US stocks.
  • MBII's price/sales ratio is 4.06; that's higher than the P/S ratio of 71.98% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to MARRONE BIO INNOVATIONS INC are MASS, TRVN, RNLX, HTGM, and INTZ.
  • MBII's SEC filings can be seen here. And to visit MARRONE BIO INNOVATIONS INC's official web site, go to www.marronebio.com.

MBII Valuation Summary

  • MBII's price/sales ratio is 4.5; this is 95.65% higher than that of the median Basic Materials stock.
  • MBII's price/sales ratio has moved down 28.1 over the prior 98 months.
  • MBII's price/earnings ratio has moved down 5.2 over the prior 98 months.

Below are key valuation metrics over time for MBII.

Stock Date P/S P/B P/E EV/EBIT
MBII 2021-09-03 4.5 5.2 -10.9 -12.9
MBII 2021-09-02 4.4 5.1 -10.6 -12.7
MBII 2021-09-01 4.4 5.1 -10.7 -12.8
MBII 2021-08-31 4.4 5.1 -10.6 -12.7
MBII 2021-08-30 4.3 5.0 -10.5 -12.5
MBII 2021-08-27 4.6 5.3 -11.2 -13.3

MBII Growth Metrics

    Its 5 year revenue growth rate is now at 128.47%.
  • The 2 year revenue growth rate now stands at 46.4%.
  • The 5 year net income to common stockholders growth rate now stands at -17.47%.
Over the past 49 months, MBII's revenue has gone up $26,032,000.

The table below shows MBII's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-03-31 44.369 -13.34 -20.889
2021-12-31 44.31 -9.961 -16.554
2021-12-31 44.31 -9.961 -16.554
2021-09-30 41.21 -13.93 -15.452
2021-06-30 40.182 -14.48 -16.57
2021-03-31 39.762 -14.684 -16.405

MBII's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MBII has a Quality Grade of C, ranking ahead of 40.3% of graded US stocks.
  • MBII's asset turnover comes in at 0.494 -- ranking 59th of 89 Chemicals stocks.
  • SNES, WDFC, and KRO are the stocks whose asset turnover ratios are most correlated with MBII.

The table below shows MBII's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.494 0.614 -0.347
2021-03-31 0.500 0.610 -0.352
2020-12-31 0.493 0.596 -0.455
2020-09-30 0.494 0.581 -0.604
2020-06-30 0.460 0.571 -0.838
2020-03-31 0.436 0.551 -0.908

MBII Price Target

For more insight on analysts targets of MBII, see our MBII price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $1.99 Average Broker Recommendation 1.5 (Moderate Buy)

MBII Stock Price Chart Interactive Chart >

Price chart for MBII

MBII Price/Volume Stats

Current price $0.80 52-week high $1.55
Prev. close $1.00 52-week low $0.55
Day low $0.75 Volume 7,393,600
Day high $1.02 Avg. volume 919,497
50-day MA $1.07 Dividend yield N/A
200-day MA $0.88 Market Cap 145.56M


MBII Latest News Stream


Event/Time News Detail
Loading, please wait...

MBII Latest Social Stream


Loading social stream, please wait...

View Full MBII Social Stream

Latest MBII News From Around the Web

Below are the latest news stories about Marrone Bio Innovations Inc that investors may wish to consider to help them evaluate MBII as an investment opportunity.

Koppers (KOP) Q4 Earnings Beat Estimates

Koppers (KOP) delivered earnings and revenue surprises of 14.93% and 1.56%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 23, 2022

Marrone Bio Innovations CFO Sue Cheung to step down

Marrone Bio Innovations (NASDAQ:MBII) said CFO Sue Cheung will resign for personal reasons, effective Mar. 9. LaDon Johnson, a director with CFO Systems, has been appointed interim CFO on a consulting basis while MBII begins a national search for a permanent CFO....

Seeking Alpha | February 22, 2022

Marrone Bio Announces CFO Transition

RALEIGH, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, announced today a transition of its Chief Financial Officer role. Current CFO Sue Cheung has chosen to resign for personal reasons, effective March 9, 2022. LaDon Johnson, a director with CFO Systems, has been appointed interim CFO on a consulting basis while the company begins a national search for a permanent CFO. “We ap

Yahoo | February 22, 2022

Marrone Bio Innovations Inc. (NASDAQ: MBII) Stock Seems Like A Good Option

Marrone Bio Innovations Inc. (NASDAQ:MBII) shares, rose in value on Friday, 02/18/22, with the stock price down by -2.92% to the previous days close as strong demand from buyers drove the stock to $0.65. Actively observing the price movement in the last trading, the stock closed the session at $0.67, falling within a range of Marrone Bio Innovations Inc. (NASDAQ: MBII) Stock Seems Like A Good Option Read More »

Stocks Register | February 19, 2022

Marrone Bio Innovations (NASDAQ:MBII) investors are sitting on a loss of 74% if they invested a year ago

It's not a secret that every investor will make bad investments, from time to time. But it should be a priority to...

Yahoo | February 18, 2022

Read More 'MBII' Stories Here

MBII Price Returns

1-mo N/A
3-mo -31.03%
6-mo -27.27%
1-year -15.53%
3-year -42.03%
5-year -30.43%
YTD 11.08%
2021 -42.38%
2020 23.76%
2019 -31.29%
2018 33.64%
2017 -48.60%

Continue Researching MBII

Here are a few links from around the web to help you further your research on Marrone Bio Innovations Inc's stock as an investment opportunity:

Marrone Bio Innovations Inc (MBII) Stock Price | Nasdaq
Marrone Bio Innovations Inc (MBII) Stock Quote, History and News - Yahoo Finance
Marrone Bio Innovations Inc (MBII) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7351 seconds.